Neurology · Parkinson's Disease
Soturi
Parkinson's Program · Newel Health
A digital ecosystem for personalized Parkinson's care, integrating wearables, biomarkers, and real-time dosing support.
Current status
POC / Development
Target milestone
Dose algorithm 2026
Study centers
3 active
MJF Foundation grant
$2.5M Phase 1
Target compliance
The problem
Parkinson's in a fragmented care system.
Parkinson's disease is a rising burden in aging societies, with limited support available between clinical encounters. Patients and caregivers must manage complex medication schedules, fluctuating symptoms, and lifestyle routines with little ongoing guidance.
Standard care offers only brief check-ins, leaving patients to self-manage the majority of their condition alone, and neurologists without the continuous data needed to make informed dosing decisions.
The solution
What is Soturi?
Soturi is a digital solution for personalized Parkinson's care. It combines a mobile app, wearable sensors, and digital biomarkers to track symptoms and medication adherence in real time. A clinical dashboard gives healthcare professionals continuous access to patient data, while a decision support system recommends individualized dose adjustments using pharmacological models.
For patients
Patient Reported Outcomes & Medication Monitoring
Structured daily logging of symptoms and medication intake
Education Programs
Speech therapy and exercise guidance
Symptom Monitoring
Through integrated wearable sensor technology
Mobile App
Intuitive interface for daily data collection and engagement
For clinicians
Clinical Dashboard
Remote monitoring with real-time access to patient data
Dose Optimization Decision Support Tool
AI-powered recommendations for individualized levodopa adjustments
Medication List & Adherence Tracking
Full medication history and adherence reporting
North star vision
Soturi's long-term goal is a closed-loop system that continuously monitors symptoms and automatically adjusts treatment in real time, enabling truly personalized Parkinson's care at scale.
Clinical evidence
Early data. Strong signal.
| Metric | Value |
|---|---|
| Study centers | 3 |
| Patients involved | 60+ |
| Average daily data logged | 12 hours |
| Phase 1 grant (MJF Foundation) | $2.5M |
Study participants logging data an average of 12 hours per day since study start
Neurologists in study centers are requesting to use Soturi for additional patients due to its clinical utility
Framework is expandable to other neurodegenerative disorders beyond Parkinson's
Interested in partnering on Soturi?
Soturi is actively seeking pharma and health system partners for co-development, clinical integration, and commercialization. Backed by Orion Pharmaceuticals and the Michael J. Fox Foundation.
info@newel.health · Newel Health Srl, Largo Abate Conforti, 84121 Salerno, Italy